jrnls.org logo
Submit

BROWSE ALL JOURNALS

Type 2 letters to search all 19 journals

SEE ALL 19 JOURNALS
International Journal of Pharmaceutical InvestigationNOW IN
Review

Emerging Trends in Silver Nanoparticle Therapies for Breast Cancer: A Comprehensive Review

1, 2, 2, 2, 2, 2, 2, 2, 1★★ Corresponding author

  1. 1Shri Vishnu College of Pharmacy, Bhimavaram, Andhra Pradesh, INDIA.
  2. 2Doctor of Pharmacy, Shri Vishnu College of Pharmacy, Bhimavaram, Andhra Pradesh, INDIA.

CORRESPONDENCE

Rama Rao Vadapalli

M.Pharm.,Ph.D, Associate Professor, Shri Vishnu College of Pharmacy, Bhimavaram, Andhra Pradesh, INDIA

vadapalli26@gmail.com

Received: 15-05-2026; Revised: 24-07-2026; Accepted: 03-09-2026.

Volume 17, Issue 1 · pp. 21–29 · 2026 · DOI: 10.5530/ijpi.20270233

View on IJPI original site ↗

ABSTRACT

Breast cancer remains a ubiquitous malignancy affecting women across the world, especially in aggressive subtypes like triple-negative breast cancer and HER2-positive tumors. Although conventional modalities like chemotherapy and targeted monoclonal antibodies have improved outcomes, challenges including drug resistance and systemic toxicity persist. Recent advancements in nanotechnology, particularly the development of silver nanoparticles, have promising effects in cancer therapy due to their unique properties and targeted drug delivery. Silver nanoparticles possess potent anticancer activity through mechanisms such as oxidative stress, regulation of cellular metabolism, and targeted drug delivery through passive or active mechanisms. Eco-friendly green synthesis methods result in biological activities like anticancer, antibacterial, antiviral, and antifungal. This review highlights the delivery mechanisms of these AgNPs, emphasizing their emerging role as a novel and effective therapeutic option for breast cancer management.

KEYWORDS

0% READ

FULL TEXT

INTRODUCTION

Breast cancer is the most frequently diagnosed cancer among women and a dominant cause of mortality, with an estimated 310,720 new cases and 42,250 deaths anticipated in 2024 alone. The disease is classified into molecular subtypes, including Luminal A, Luminal B, HER2-enriched, and Triple-Negative Breast Cancer (TNBC) Nanotechnology offers advanced delivery systems that provide better stability, targeted delivery, and extended blood circulation compared to traditional methods. While few nanoscale systems like paclitaxel-albumin complexes are FDA-approved, research into metal nanoparticles like AgNPs continues to expand (Figure 1).

Figure 1: Mechanism of Silver Nanoparticles (AgNPs) (original image created with BioRender) The graphical abstract illustrates the mechanism of Silver Nanoparticles (AgNPs), including ROS generation, DNA damage, and apoptosis in breast cancer cells compared to normal cells.

Numerous delivery systems are available, one of them is nanomedicine that have been used for drug delivery. It is more advantageous than traditional methods due to its targeted drug delivery system, stability and extended blood circulation (Fraguas-Sánchez et al., 2025 and Fu et al., 2025). Nanotechnology provides different systems or carriers that can deliver the drug at targeted site. Despite extensive research in Pharmaceutical nanotechnology, the FDAs complete approval process has been successfully completed by just a handful of nanoscale drug delivery systems, including the landmark paclitaxel-albumin complex and sterically stabilized liposomal doxorubicin (Mugundhan et al., 2024). The results of various studies are integrated into the thematic sections below: Types of Nanoparticles: NPs are classified into carbon, metal, ceramic, semiconductor, and polymeric types. Biological Activity: Plant-derived AgNPs (from leaves, seeds, or roots) show diverse activities, including antibacterial, anticancer, and antiviral properties.

Breast Cancer

Breast cancer is a worldwide risk with high death rates (Martínez-Sanmiguel et al., 2024). Breast cancer exhibit significant molecular heterogeneity, with distinct classifications emerging from differential expression patterns of Harmone receptors and growth factor proteins. One subtype is Triple Negative Breast Cancer (TNBC), named due to lack of progesterone receptors, estrogen receptors and Human Epidermal Growth Factor Receptor-2(HER-2) which are commonly present in other breast cancers (Lehmann et al., 2011). Most of the breast cancers are due to overexpression of the Human Epidermal Growth Factor Receptor 2(HER2) (Choong et al., 2022). Monoclonal antibodies like trastuzumab had significantly raised the prognosis of patients for the patients with overexpression of HER2 (Chen et al., 2023; Vega-Rubín-De-Celis et al., 2023). PYROTINIB, a small molecule has shown significant enhancement in both disease free and overall survival rates among the patients diagnosed with HER2 positive breast cancer12. There are many adverse effects with the existing therapy and development of resistance due to genetic mutations. Therefore there are recent advances in cancer therapy with nanostructures like metal nanoparticles and these are available and can be formulated through a Eco-friendly environment to minimise the adverse effects with hazardous chemicals. Nanomaterials are approved as anticancer agents by the FDA. Nanoparticles are less toxic and can be used as Biomedicine (Liu et al., 2023; Yazdi et al., 2016).

Nanoparticles As Anticancer Agents

Nanotechnology has been a prominent field of research since late 20th century. Nanotechnology has enabled the creation of a wide variety of materials at nanoscale nanoparticles are one of those wide variety of materials (Khan et al., 2019). Nanoparticle is defined as a particle with size lessthan 100 nm or ultrafine particle nanoparticles have different applications in various sectors ranging from carrier for drug to the target site and gene delivery into tumors. Nanomaterials differ from other bulk substances based on the size of the particle (Zahra et al., 2020).

Types of Nanoparticles

Depending on physical and chemical properties nanoparticles have been classified as carbon NPs, metal NPs, Ceramics NPs, Semiconductor NPs, Polymeric NPs (Khan et al., 2019).

Carbon Nanoparticles

Nanotubes and Fullerences are the two major types of carbon based NPs. These Nanoparticles feature various attachment sites on their surface, which can be modifies to connect with tissues, increasing their usage in targeted applications. Carbon nanotubes are essentially hollow, tube like structures formed by rolling a flat, single atom-thick layer of carbon atoms (Graphene) into a smooth, unbroken cylinder. These rolled sheets can be single sheet or double or multiple. If the sheets are single rolled, they can be called as Single Walled Nanotubes (SWNTs) and if they are multiple, they can be called as Multiple Walled carbon Nanotubes (MWNTs) (Bosi et al., 2003; Pagona et al., 2006).

Metal nanoparticles

Metal nanoparticles are prepared from the precursors of metals. Nanoparticles of metals such as copper, Silver, Gold have a broad range of absorption spectra. Metal nanoparticles have wide applications in research area (Khan et al., 2019). These nanoparticles consist of a dielectric center coted with a nanoscale gold layer, forming a core shell spherical geometry. These nanoparticles possess unique optical and chemical features that enhance their performance in imaging and therapeutic biomedical applications (Hirsch et al., 2006). Recently silver nanoparticles have made to explore their properties and potential uses such as antibacterial and anticancer treatments (Chen et al., 2009; Sun et al., 2003). Silver Nanoparticle (AgNPs) possesunstapped potential when compared to the relatively stable Gold Nanoparticles (AuNPs) (Desireddy et al., 2013).

Ceramics Nanoparticles

Ceramic Nanoparticle is inorganic materials that have characterized porous nature and recently gained prominence as carriers for drug delivery (Cherian et al., 2000). They have wide applications in catalysis, photodegradation of dyes etc. (Zahra et al., 2020).

Semiconductor Nanoaparticles

Semiconductor material contains both conductor and semiconductor properties and exhibit various applications. They play an important role in Photocatalysis, electronic devices (Khan et al., 2019).

Polymeric Nanoparticles

These nanoparticles are derived from organic compounds and a distinct term called Polymer Nanoparticle (PNP) is used for it. Attaching polymers to proteins decreases immunogenicity extends plasma half-life and improve protein stability. By utilizing the enhancing permeability and retention effect, polymer-drug conjugates specifically accumulate in tumors and enable cellular level drug delivery after being internalized (Lee et al., 2006). Importance of nanoparticles is because of their adaptable properties and their enhanced functioning or activity over their parent material. There are different methods of synthesizing the nanoparticles which may be hazardous and recent innovative using biological methods that are eco-friendly, safe and productive and this also called as green synthesis (Khan et al., 2019).

Synthesis of Nanoparticles

Nanoparticles can be prepared by the three methods such as physical method, Chemical method and green method (Divya et al., 2018; Hemmati et al., 2020). Chemical methods used for the synthesis of silver nanoparticles have a common strategy of reducing and stabilising agents to monitor different sizes and different shapes for the targeted delivery and the toxicity of this chemical method is due to reducing agents. Methods that produce nanoparticles with high energy input are with reduced stability, which results in unwanted chemical reactions and agglomeration, thus unsuitable for in vivo drug delivery. Therefore the usage of toxic organic solvents hinder their application in drug delivery for lung and breast cancer. Correspondingly methods like UV- initiated photoreduction, irradiation and electrochemical synthesis need a lot of energy to male nanoscale particles. Even Tollen’s method which uses carbohydrate still requires ammonia that results in toxic particles that makes them not entirely safe for drug delivery (Malik et al., 2018). Most of the studies are suggesting the use of green synthesis due to their use of nontoxic chemicals and low cost (Mescola et al., 2017; Peter et al., 2016; Castillo-Henríquez et al., 2020). Green synthesis means the use of plant and fruit extracts as reducing and stabilizing agents. For example eco-friendly preparation using orange peel extract which contains polyphenols and polysaccharides act as reducing agents, carboxylic, amino acid and citric acid that act as stabilising agents (Skiba et al., 2019). The most active constituent in orange is flavonoids that shows anticancer property (Tajaldini et al., 2020).

Preparation of AgNPs and Ag/RGONCs

Silver nitrate, Graphene Oxide and extract of orange peelare necessary for nanoparticle formulation. Silver nitrate was dissolved in deionized water to obtain a 1 nm aqueous solution. 50 mg of Graphene oxide was dissolved in 100 mL of deionised water. A mixture was prepared containing 160 mL of silver nitrate solution, 20 mL orange peel extract, and 20 mL graphene oxide suspension, with continuous mild agitation. The reaction mixture was kept at dark conditions at room temperature for 12 hr and finally the obtained powder was dried at 90ºC for at least 3 hr and ground into a fine powder for further characterization (Ahamed et al., 2025). Table 1 shows the source and the activity exhibited by the nanoparticle.

Table 1: Source and the activity exhibited by the Nanoparticle.
Sl. No.Plant SpeciesParts of plant used for generation of nanoparticlesSize of nanoparticleShape of nanoparticleActivityReferences
01.Youngia japonica, Melaleuca alternifolia and AspiliaplurisetaLeaf extractAverage size of 20 nmSpherical shapeAntibacterial activity, Antifungal and antiviral, Antimicrobial propertiesRamadan et al. 2020
02.Trigonellafoenum -graecum, Tectona grandis, Phoenix sylvestris, Phoenix dactyliferaSeedsDiameter of 33.93 nmRoughly sphericalAntibacterial, Anticancer, Antiviral, Antifungal, AntimicrobialVarghese et al. 2019
03.Chlorophytum borivilianumFrom FlowersDiameter of 52 nmRoughly sphericalAntimicrobialHuang et al. 2019
04.Dorema ammoniacumStemAverage size of 15 nmRoughly sphericalAntibacterialZandpour et al. 2018
05.Zingiber officinale, Butea monosperma, Syzygium cumini, Diospyros montanaFrom Bark13 nm diameterSphericalAntibacterialYang et al. 2017, Das et al. 2018
06.Allium fistulosum, Lepidium draba, Angelica pubescens, Arctium lappaRootsAverage size of 5 nmSphericalAntibacterial, Antifungal activityBenakashani et al. 2017, Markus et al. 2017
07.Sida cordifolia, Sida acuta, Elaeagnus umbellata, Rheum ribesWhole plantAverage size of 50 nmSphericalAntibacterialAygün et al. 2019, Seleimanet al. 2003

Drug delivery system

Nanoparticles ranging from 1 to 100 nm have emerged as pivotal agents in the realm of drug delivery owing to their unique physiochemically properties and versatile functionality. These nanoscale constructs can be engineered to transport therapeutic compounds with high specificity to designated biological targets. Their ability to markedly enhance pharmacological outcomes positions them as a cornerstone in the evolution of precision medicine. A fundamental challenge in the treatment of many pathological conditions lies in the targeted localisation of the therapeutic agents. Conventional formulations often suffer from suboptimal biodistribution, limited therapeutic index and poor selectivity, thereby compromising the clinical efficacy (Seleiman et al., 2017) (Figure 2).

Figure 2: Types of Nanoparticles (original image created with BioRender).

Advanced controlled release systems utilising nanoparticles enable site specific drug deposition, thereby maximising therapeutic impact on diseased tissue and minimising the systemic toxicity (KhademSadigh et al., 2025). Nanoparticle mediated delivery has been categorised into five functional modalities, they are Diagnostic imaging, oncologic therapeutics,photosensitizer transport, nucleic acid delivery and protein-based interventions. Each modality harnesses the precsion of nanotechnology to refine treatment accuracy, attenuate adverse effects and elevate clinical outcomes. Collectively these innovations are reshaping the landscape of contemporary medicine, particularly in the domains of molecular diagnostics and targeted therapeutics (Islam et al., 2025). Targeted drug delivery system has been considered as favorable compatibility within the human systems. These systems effectively reduced the survival rates of breast cancer lines 4T1 and MCF-7, while showing the minimal toxicity towards endothelial cells. Additionally they exhibited potent anti-tumor activity in live animal momodels. Various polymer- based delivery platforms have been thoroughly explored for treating initial and advanced stages of breast (Salari et al., 2022).

Applications

From the advanced drug administration methods Nanoparticle drug delivery had been adopted as the most advanced method (Kuddushi et al., 2025).The U.S Food and Drug administration has previously sanctioned multiple nanoparticle mediated chemotherapy platforms for breast cancer treatment, with numerous additional systems currently undergoing clinical evaluation. These drug delivery constructs based on polymeric nanocarriers, liposomal formulations, and paclitaxel loaded nanoparticles (Yang et al., 2022; Zhou et al., 2023). The Polymeric nanoparticles, in particular offer customizable surface architecture that can be engineered for permeability, biocompatibility and biodegradability. These carriers are synthesised using synthetic polymers or natural polymers. Their advantages include high drug encapsulation efficiency, scalable production and tunable release kinetics (Zhang et al., 2024) PLGA (Poly(Lactic-Co-Glycolic Acid)) is a synthetic polymer has the ability to inhibit p-glycoprotein activity, a mechanism that plays a critical role in overcoming multidrug resistance. Nanoparticles are also employed in combination therapy approaches for breast cancer, where multiple therapeutic agents are co-delivered to achieve synergistic effects. This strategy has been shown to enhance the treatment outcomes, mitigate the emergence of drug resistance and improve patient survival rates (Triantafyllakou et al., 2022). While siRNA loaded nanocarriers have demonstrated promising therapeutic potential, their efficacy is still subject to the complexities of in vivo interactions. To better evaluate novel treatment modalities, patient derived xenograft mouse models are considered superior to conventional human breast cancer cell lines. These models retain the molecular, cellular, genomic and epigenomic characteristics of actual tumours, offering a more accurate platform for translational research (Wang et al., 2024; Marinov et al., 2025). The prism analogy aptly represents the multifaceted nature of nanoparticles, high lightening their ability to adapt and optimise drug delivery systems for specific pathological conditions. These innovations not only enhance drug bioavailability but also minimise systemic toxicity and elevate therapeutic efficacy (Islam et al., 2025) (Figure 3).

Figure 3: Flowchart of Methods of synthesis of nanoparticles (original image created with BioRender).

Nanoparticle-driven advances in precision drug delivery

Nanotechnology enabled therapeutic delivery systems are revolutionizing modern healthcare by facilitating precise and efficient transport of bioactive compounds. These platforms enhance drug solubility, molecular stability and site specific targeting by leveraging the distinct physiochemical traits of nanomaterials such as high surface to volume ration, turnable surface chemistry and ultra small dimensions. Recent advancements focuses on engineering ecofriendly and physiologically compatible nanovehicles, including lipid based vehicles, polymeric nanostructures and inorganic nanosysytems. Cutting edge surface engineering techniques and stimuli triggered release strategies are broadening their utility across diverse biomedical domains notably in immunomodulation, tissue regeneration and oncological therapies60.The enhanced precision in targeting, regulating release profiles and improved dissolution and molecular stability provided by these nanocarrier systems significantly elevate the pharmacological availability of therapeutic agents. Moreover, their versatile drug - encapsulation potential enables the delivery of a broad spectrum of medicinal compounds while effectively navigating physiological barriers. These technological strides are paving the way for more refined and efficacious approaches to clinical drug administration (Tian et al., 2021; Guo et al., 2024).

  1. Enhanced targeting efficiency,
  2. Controlled drug release,
  3. Improved drug solubility,
  4. Versatility in drug loading,
  5. Overcoming biological barriers.

Delivery of nanoparticles to cancerous cells

Nanoparticles are delivered to cancerous cells in two main ways i.e active and passive targeting. In active targeting (shown in Figure 4) nanoparticles are bind to specific receptors on cancer cells. These receptors are common on cancer cells than on normal cells. The receptors must be easily accessible and present in high enough numbers. Various molecules like antibodies peptides, nucleic acids, sugars and small vitamins can act as ligands for active targeting. Whereas passive targeting (shown in Figure ) relies on the natural tendency of certain molecules to accumulate in tumors due to their leaky blood vessels and poor lymphatic drainage and this is known as EPR effect (Enhanced permeation and retention effect). When tumors grow beyond a certain size, they don’t get enough oxygen causing some cells to die and new blood vessels to form. This allows nanoparticles to enter and stay in tumor (Malik et al., 2018).

Figure 4: Nanoparticle Drug delivery systems (original image created with BioRender).

PHARMACOLOGICAL ACTIVITIES OF NANOPARTICLES

Antibacterial Activites

Metallic nanoparticles exhibit antibacterial property by disrupting the cell membrane and inhibton of protein synthesis (Sondi and Salopek-Sondi, 2004). Higher the concentration of nanoparticles higher the membrane permeability into the bacteria (Kasthuri et al., 2009). Silver nanoparticles are biosynthesized by a single step process using Citrus sinensis peel extract which act as reducing agent. Thisnanoparticles are active against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus (Kaviya et al., 2011).

Antifungal Activity

The Silver nanoparticle derived from plants have demonstrated evident membrane damage in candida species as well as disruption of fungal intracellular components ultimately leading to the destruction of cell function (Logeswari et al., 2025). Antifungal agents are associated with significant adverse effects, including hepatotoxicity and nephrotoxicity. The fungal cell wall is composed of a dense polymeric structure primarily made up of lipids and proteins. The silver nanoparticles have multifunctional activities against the fungus and disrupt the growth of fungal cells (Gardea-Torresdey et al., 2002).

Anti-Plasmodial Activity

The metallic silver nanoparticles efficiently control the malarial production. Active constituents like quinine, artemisinin and aromatic compounds used against resistant strains of malaria parasites (Jayaseelan et al., 2011).

Anticancer Activity

Cancer is the uncontrolled division of cells. This uncontrolled cell cycles can be disrupted using bio-based nanoparticles. Metallic nanoparticles are effective against different types of cancerous cells like Hep 2, HCT 116, and HeLa cell lines (Raghunandan et al., 2011). Nanoparticles helps in regulating the production of free radicals. Free radicals offer trigger cell proliferation and disrupt the normal cellular functions. This oxidative stress led to significant damage in biological systems affecting the integrity and stability of cells (Dipankar et al., 2012). Similarly, treatment of the MCF-7 cancer cell line with silver nanoparticles has maintained to the concentration of biomolecules withing the cells leading to regulation of cell metabolism (Das et al., 2011). Metallic nanoparticles consists of innovative implementations in aiding diagnosis and treatment of different types of cancers and retroviral diseases. The advent of biologically synthesized nanoparticles marks a step forward, offering the ability to target malignant deposits effectively while sparing normal cells from the damage (Suman et al., 2013).

Antiviral Activity

Bio-based nanoparticles have a promising alternative for treating and controlling the viral pathogens. This metallic silver nanoparticles serve as a potent broad spectrum antiviral agent, prevent the entry of viral pathogen in to the host cell. These nanoparticles posses multiple binding sites that attach to gp120 of the viral membrane and act as virucidal.

The results of various studies are integrated into the sections below: Types of Nanoparticles: NPs are classified into carbon, metal, ceramic, semiconductor, and polymeric types.Biological Activity: Plant-derived AgNPs (from leaves, seeds, or roots) show diverse activities, including antibacterial, anticancer, and antiviral properties.

CONCLUSION

Employing silver nanoparticles in biomedical research represents a cutting-edge development for aggressive breast cancer subtypes. Their unique physiochemical properties, such as high surface area and the ability to generate reactive oxygen species, allow AgNPs to offer enhanced therapeutic efficacy with lower systemic toxicity compared to conventional therapies.

ACKNOWLEDGEMENT

The authors are thankful to Shri Vishnu College of Pharmacy, Bhimavaram for providing the necessary facilities.

ABBREVIATIONS

AgNPs
Silver Nanoparticles
HER2
Human Epidermal Growth Factor Receptor-2
TNBC
Triple-negative breast cancer
FDA
Food and Drug Administration
ROS
Reactive Oxygen Species
PLGA
Poly(lactic-co-glycolic acid)
EPR
Enhanced permeation and retention effect
siRNA
Small interfering RNA
AuNPs
Gold nanoparticles
SWNTs
Single Walled Nano Tubes
MWNTs
Multiple walled carbon nanotubes
PNP
Polymer Nano Particle
RGONCs
Reduced Graphene Oxide Nanocomposites.

CONFLICT OF INTEREST

The authors declare that there is no conflict of interest.

ETHICAL STATEMENT

These are not present in the sources as it is a review of existing literature

SUMMARY

Nanoparticles act as multifunctional vehicles that revolutionize healthcare by facilitating precise transport of bioactive compounds, improving drug solubility, and navigating biological barriers to elevate clinical outcomes.

REFERENCES

As published

Showing references and in-text citations exactly as published.

  1. 1.Afzal, M. Z.; Vahdat, L. T.. Evolving management of breast cancer in the era of predictive biomarkers and precision medicine. Journal of Personalized Medicine. 2024;14(7):719. https://doi.org/10.3390/JPM14070719CrossrefGOOGLE SCHOLAR
  2. 2.Ahamed, M.; Akhtar, M.; Khan, M.; Polymers, HA; MAhamed, MJ; Akhtar, MAM Khan. A novel green preparation of Ag/RGO nanocomposites with highly effective anticancer performance. mdpi.com. 2021.GOOGLE SCHOLAR
  3. 3.Ali, S.; Perveen, S.; Ali, M.; Jiao, T.; Sharma, A. S.; Hassan, H. et al. Bioinspired morphology-controlled silver nanoparticles for antimicrobial application. Materials Science and Engineering. C, Materials for Biological Applications. 2020;108:Article 110421. https://doi.org/10.1016/J.MSEC.2019.110421CrossrefGOOGLE SCHOLAR
  4. 4.Ansari, M. A.; Alzohairy, M. A.. One-pot facile green synthesis of silver nanoparticles using seed extract of Phoenix dactylifera and their bactericidal potential against MRSA. Evidence-Based Complementary and Alternative Medicine. 2018;2018(1):1860280. https://doi.org/10.1155/2018/1860280CrossrefGOOGLE SCHOLAR
  5. 5.Aygün, A.; Gülbağça, F.; Nas, M. S.; Alma, M. H.; Çalımlı, M. H.; Ustaoglu, B. et al. Biological synthesis of silver nanoparticles using Rheum ribes and evaluation of their anticarcinogenic and antimicrobial potential: A novel approach in phytonanotechnology. Journal of Pharmaceutical and Biomedical Analysis. 2020;179:Article 113012. https://doi.org/10.1016/J.JPBA.2019.113012CrossrefGOOGLE SCHOLAR
  6. 6.Benakashani, F.; Allafchian, A.; Jalali, S. A. H.. Green synthesis, characterization and antibacterial activity of silver nanoparticles from root extract of Lepidium draba weed. Taylor &FrancisFBenakashani, A Allafchian, SAH JalaliGreen chemistry letters and reviews, 2017•Taylor and Francis. Green Chemistry Letters and Reviews. 2017;10(4):324–330. https://doi.org/10.1080/17518253.2017.1363297CrossrefGOOGLE SCHOLAR
  7. 7.Berikkhanova, K.; Taigulov, E.; Bokebaev, Z.; Kusainov, A.; Tanysheva, G.; Yedrissov, A. et al. Drug-loaded erythrocytes: Modern approaches for advanced drug delivery for clinical use. Heliyon. 2024;10(1):e23451. https://doi.org/10.1016/J.HELIYON.2023.E23451CrossrefGOOGLE SCHOLAR
  8. 8.Bharathi, D.; Diviya Josebin, M.; Vasantharaj, S.; Bhuvaneshwari, V.. •Springer. Biosynthesis of silver nanoparticles using stem bark extracts of Diospyros montana and their antioxidant and antibacterial activities. Journal of Nanostructure in Chemistry. 2018;8(1):83–92. https://doi.org/10.1007/S40097-018-0256-7CrossrefGOOGLE SCHOLAR
  9. 9.Bosi, S.; Da Ros, T.; Spalluto, G.; Prato, M.. Fullerene derivatives: An attractive tool for biological applications. European Journal of Medicinal Chemistry. 2003;38(11-12):913–923. https://doi.org/10.1016/j.ejmech.2003.09.005CrossrefGOOGLE SCHOLAR
  10. 10.Castillo-Henríquez, L.; Alfaro-Aguilar, K.; Ugalde-Álvarez, J.; Vega-Fernández, L.; Montes de Oca-Vásquez, G. M.; Vega-Baudrit, J. R.. Green synthesis of gold and silver nanoparticles from plant extracts and their possible applications as antimicrobial agents in the agricultural area. Nanomaterials. 10(9):1763. https://doi.org/10.3390/NANO10091763CrossrefGOOGLE SCHOLAR
  11. 11.Chandra Sekhar, E.; Rao, V. K.. KS, Madhusudana Rao K, Bahadur Alisha S.A simple biosynthesis of silver nanoparticles from Syzygium cumini stem bark aqueous extract and their spectrochemical and antimicrobial studies. Journal of Applied Pharmaceutical Science. japsonline.com. 2018;8(01). https://doi.org/10.7324/JAPS.2018.8111CrossrefGOOGLE SCHOLAR
  12. 12.Chen, D.; Qiao, X.; Qiu, X.; Chen, J.. Synthesis and electrical properties of uniform silver nanoparticles for electronic applications. Journal of Materials Science. 2009;44(4):1076–1081. https://doi.org/10.1007/S10853-008-3204-YCrossrefGOOGLE SCHOLAR
  13. 13.Chen, G.; Zeng, L.; Bi, B.; Huang, X.; Qiu, M.; Chen, P. et al. Engineering bifunctional calcium alendronate gene-delivery nanoneedle for synergistic Chemo/Immuno-therapy against HER2 positive ovarian cancer. Advanced Science. 2023;10(14):e2204654. https://doi.org/10.1002/ADVS.202204654CrossrefGOOGLE SCHOLAR
  14. 14.Cherian, A. K.; Rana, A. C.; Jain, S. K.. Self-assembled Carbohydrate-Stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Development and Industrial Pharmacy. 2000;26(4):459–463. https://doi.org/10.1081/DDC-100101255CrossrefGOOGLE SCHOLAR
  15. 15.Choong, G. M.; Cullen, G. D.; O’Sullivan, C. C.. Evolving standards of care and new challenges in the management of HER2-positive breast cancer. CA: A Cancer Journal for Clinicians. 2020;70(5):355–374. https://doi.org/10.3322/CAAC.21634CrossrefGOOGLE SCHOLAR
  16. 16.Das, M.; Smita, S. S.. •Springer. Biosynthesis of silver nanoparticles using bark extracts of Butea monosperma (Lam.) Taub. and study of their antimicrobial activity. SpringerM das SS SmitaApplied Nanoscience. 2018;8(5):1059–1067. https://doi.org/10.1007/S13204-018-0721-0CrossrefGOOGLE SCHOLAR
  17. 17.Das, R. K.; Gogoi, N.; Bora, U.. Green synthesis of gold nanoparticles using Nyctanthes arbortristis flower extract. Bioprocess and Biosystems Engineering. 2011;34(5):615–619. https://doi.org/10.1007/S00449-010-0510-YCrossrefGOOGLE SCHOLAR
  18. 18.Das, S.; Das, J.; Samadder, A.; Bhattacharyya, S. S.; Das, D.; Khuda-Bukhsh, A. R.. Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloids and Surfaces. B, Biointerfaces. 2013;101:325–336. https://doi.org/10.1016/J.COLSURFB.2012.07.008CrossrefGOOGLE SCHOLAR
  19. 19.Desireddy, A.; Conn, B. E.; Guo, J.; Yoon, B.; Barnett, R. N.; Monahan, B. M. et al. Ultrastable silver nanoparticles. Nature. 2013;501(7467):399–402. https://doi.org/10.1038/NATURE12523CrossrefGOOGLE SCHOLAR
  20. 20.Dipankar, C.; Murugan, S.. The green synthesis, characterization and evaluation of the biological activities of silver nanoparticles synthesized from Iresine herbstii leaf aqueous extracts. Colloids and Surfaces. B, Biointerfaces. 2012;98:112–119. https://doi.org/10.1016/J.COLSURFB.2012.04.006CrossrefGOOGLE SCHOLAR
  21. 21.Divya, K. S.; Chandran, A.; Reethu, V. N.; Mathew, S.. Enhanced photocatalytic performance of RGO/Ag nanocomposites produced via a facile microwave irradiation for the degradation of rhodamine b in aqueous solution. Applied Surface Science. 2018;444:811–818. https://doi.org/10.1016/J.APSUSC.2018.01.303CrossrefGOOGLE SCHOLAR
  22. 22.Dong, Y.; Li, W.; Gu, Z.; Xing, R.; Ma, Y.; Zhang, Q. et al. Inhibition of HER2-positive breast cancer growth by blocking the HER2 signaling pathway with HER2-glycan-imprinted nanoparticles. Angewandte Chemie. 2019;58(31):10621–10625. https://doi.org/10.1002/anie.201904860CrossrefGOOGLE SCHOLAR
  23. 23.Fraguas-Sánchez, A. I.; Lozza, I.; Torres-Suárez, A. I.. Actively targeted nanomedicines in breast cancer: From pre-clinal investigation to clinic. Cancers. 2022;14(5):1198. https://doi.org/10.3390/CANCERS14051198CrossrefGOOGLE SCHOLAR
  24. 24.Fu, S.; Li, G.; Zang, W.; Zhou, X.; Shi, K.; Zhai, Y.. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy. Acta Pharmaceutica Sinica. B. 2022;12(1):92–106. https://doi.org/10.1016/j.apsb.2021.08.012CrossrefGOOGLE SCHOLAR
  25. 25.Gardea-Torresdey, J.; Parsons, J.; Gomez, E. et al. (Published online 2002). Formation and growth of Au nanoparticles inside live alfalfa plants. Nano Letters. 2(4):397–401. https://doi.org/10.1021/NL015673CrossrefGOOGLE SCHOLAR
  26. 26.Guo, Y. X.; He, Y. X.. Nanoparticle-based drug delivery systems: An updated strategy for treating fungal keratitis. Colloid and Interface Science Communications. 2024;61:100794. https://doi.org/10.1016/j.colcom.2024.100794CrossrefGOOGLE SCHOLAR
  27. 27.Haes, A. J.; Van Duyne, R. P.. A nanoscale optical biosensor: Sensitivity and selectivity of an approach based on the localized surface plasmon resonance spectroscopy of triangular silver nanoparticles. Journal of the American Chemical Society. 2002;124(35):10596–10604. https://doi.org/10.1021/ja020393xCrossrefGOOGLE SCHOLAR
  28. 28.Heinz, H.; Pramanik, C.; Heinz, O.; Ding, Y.; Mishra, R. K.; Marchon, D. et al. Nanoparticle decoration with surfactants: Molecular interactions, assembly, and applications. Surface Science Reports. 2017;72(1):1–58. https://doi.org/10.1016/J.SURFREP.2017.02.001CrossrefGOOGLE SCHOLAR
  29. 29.Hemmati, S.; Heravi, M. M.; Karmakar, B.; Veisi, H.. Green fabrication of reduced graphene oxide decorated with Ag nanoparticles (rGO/Ag NPs) nanocomposite: A reusable catalyst for the degradation of environmental pollutants in aqueous medium. Journal of Molecular Liquids. 2020;319:Article 114302. https://doi.org/10.1016/J.MOLLIQ.2020.114302CrossrefGOOGLE SCHOLAR
  30. 30.Hirsch, L. R.; Gobin, A. M.; Lowery, A. R.; Tam, F.; Drezek, R. A.; Halas, N. J. et al. Metal nanoshells. Annals of Biomedical Engineering. 2006;34(1):15–22. https://doi.org/10.1007/S10439-005-9001-8CrossrefGOOGLE SCHOLAR
  31. 31.Huang, F.; Long, Y.; Liang, Q.; Purushotham, B.; Swamy, M. K.; Duan, Y. et al. Safed Musli (Chlorophytum borivilianum L.) Callus-Mediated Biosynthesis of Silver Nanoparticles and Evaluation of their Antimicrobial Activity and Cytotoxicity against Human Colon Cancer Cells. Journal of Nanomaterials. 2019;2019(1):1–8. https://doi.org/10.1155/2019/2418785CrossrefGOOGLE SCHOLAR
  32. 32.Idrees, M.; Batool, S.; Kalsoom, T.; Raina, S.; Sharif, H. M. A.; Yasmeen, S.. Biosynthesis of silver nanoparticles using Sida acuta extract for antimicrobial actions and corrosion inhibition potential. Taylor &FrancisMIdrees. Environmental Technology. 2018;40(8):1071–1078. https://doi.org/10.1080/09593330.2018.1435738CrossrefGOOGLE SCHOLAR
  33. 33.Islam, S.; Ahmed, M. M. S.; Islam, M. A.; Hossain, N.; Chowdhury, M. A.. Advances in nanoparticles in targeted drug delivery–A review. Results in Surfaces and Interfaces. 2025;19:Article 100529. https://doi.org/10.1016/J.RSURFI.2025.100529CrossrefGOOGLE SCHOLAR
  34. 34.Jayaseelan, C.; Rahuman, A. A.; Rajakumar, G.; Vishnu Kirthi, A.; Santhoshkumar, T.; Marimuthu, S. et al. Synthesis of pediculocidal and larvicidal silver nanoparticles by leaf extract from heartleaf moonseed plant, Tinospora cordifolia Miers. Parasitology Research. 2011;109(1):185–194. https://doi.org/10.1007/S00436-010-2242-YCrossrefGOOGLE SCHOLAR
  35. 35.Kasthuri, J.; Kathiravan, K.; Rajendiran, N.. Phyllanthin-assisted biosynthesis of silver and gold nanoparticles: A novel biological approach. Journal of Nanoparticle Research. 2009;11(5):1075–1085. https://doi.org/10.1007/S11051-008-9494-9CrossrefGOOGLE SCHOLAR
  36. 36.Kaviya, S.; Santhanalakshmi, J.; Viswanathan, B.; Muthumary, J.; Srinivasan, K.. Biosynthesis of silver nanoparticles using Citrus sinensis peel extract and its antibacterial activity. Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy. 2011;79(3):594–598. https://doi.org/10.1016/J.SAA.2011.03.040CrossrefGOOGLE SCHOLAR
  37. 37.Khadem Sadigh, M.; Sayyar, Z.; Mohammadi, M. A.; Baharlounezhad, F.. Controlling the drug delivery efficiency of chitosan-based systems through silver nanoparticles and oxygen plasma. International Journal of Biological Macromolecules. 2025;294:Article 139407. https://doi.org/10.1016/J.IJBIOMAC.2024.139407CrossrefGOOGLE SCHOLAR
  38. 38.Khan, I.; Saeed, K.; Khan, I.. Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry. 2019;12(7):908–931. https://doi.org/10.1016/J.ARABJC.2017.05.011CrossrefGOOGLE SCHOLAR
  39. 39.Khoshnamvand, M.; Ashtiani, S.; Chen, Y.; Liu, J.. Impacts of organic matter on the toxicity of biosynthesized silver nanoparticles to green microalgae Chlorella vulgaris. Environmental Research. 2020;185:Article 109433. https://doi.org/10.1016/J.ENVRES.2020.109433CrossrefGOOGLE SCHOLAR
  40. 40.Kuddushi, M.; Xu, B. B.; Malek, N.; Zhang, X.. Review of ionic liquid and ionogel-based biomaterials for advanced drug delivery. Advances in Colloid and Interface Science. 2024;331:Article 103244. https://doi.org/10.1016/j.cis.2024.103244CrossrefGOOGLE SCHOLAR
  41. 41.Lee, L. J.. Polymer nano-engineering for biomedical applications. Annals of Biomedical Engineering. 2006;34(1):75–88. https://doi.org/10.1007/S10439-005-9011-6CrossrefGOOGLE SCHOLAR
  42. 42.Lehmann, B. D.; Bauer, J. A.; Chen, X.; Sanders, M. E.; Chakravarthy, A. B.; Shyr, Y. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. The Journal of Clinical Investigation. 2011;121(7):2750–2767. https://doi.org/10.1172/JCI45014CrossrefGOOGLE SCHOLAR
  43. 43.Liu, S. M.; Tu, H.-Y.; Wei, X.-W.; Yan, H.-H.; Dong, X.-R.; Cui, J.-W. et al. First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: A patient-centric phase 2 trial. Nature Communications. 2023;29(8):2079–2086. https://doi.org/10.1038/s41591-023-02461-xCrossrefGOOGLE SCHOLAR
  44. 44.Liu, SYM; Tu, HY; Wei, XW; Yan, HH; Dong, XR; Cui, JW et al. Nature Medicine, 2023•nature.com.GOOGLE SCHOLAR
  45. 45.Logeswari, P.; Silambarasan, S.. Synthesis of silver nanoparticles using Plant extract and analysis of their antimicrobial property. ElsevierPLogeswari, S Silambarasan, J AbrahamJournal of Saudi Chemical Society, 2015•Elsevier. 2015.GOOGLE SCHOLAR
  46. 46.Malik, P.; Mukherjee, T. K.. Recent advances in gold and silver Nanoparticle Based therapies for lung and breast cancers. International Journal of Pharmaceutics. 2018;553(1-2):483–509. https://doi.org/10.1016/J.IJPHARM.2018.10.048CrossrefGOOGLE SCHOLAR
  47. 47.Marinov, L.; Georgieva, A.; Toshkova, R.; Kostadinova, I.; Mangarov, I.; Toshkova-Yotova, T. et al. The effects of meloxicam, lornoxicam, ketoprofen, and dexketoprofen on human cervical, colorectal, and mammary carcinoma cell lines. Pharmacia. - Yahoo India Search Results.. 2024;71:1–12. https://doi.org/10.3897/pharmacia.71.e113677CrossrefGOOGLE SCHOLAR
  48. 48.Markus, J.; Wang, D.; Kim, Y.-J.; Ahn, S.; Mathiyalagan, R.; Wang, C. et al. Biosynthesis, characterization, and bioactivities evaluation of silver and gold nanoparticles mediated by the roots of Chinese herbal Angelica pubescens Maxim. SpringerJ Markus. Nanoscale Research Letters. 2017;12(1):46. https://doi.org/10.1186/S11671-017-1833-2CrossrefGOOGLE SCHOLAR
  49. 49.Martínez-Sanmiguel, J.. Antitumor activity of bimetallic silver/gold nanoparticles against MCF-7 breast cancer cells. DZTR. 2024.GOOGLE SCHOLAR
  50. 50.Mescola, A.; Canale, C.; Fragouli, D.; Athanassiou, A.. Controlled formation of gold nanostructures on biopolymer films upon electromagnetic radiation. Nanotechnology. 2017;28(41):415601. https://doi.org/10.1088/1361-6528/AA8337CrossrefGOOGLE SCHOLAR
  51. 51.Mugundhan, S. L.; Mohan, M.. Nanoscale strides: Exploring innovative therapies for breast cancer treatment. RSC Advances. 2024;14(20):14017–14040. https://doi.org/10.1039/D4RA02639JCrossrefGOOGLE SCHOLAR
  52. 52.Nanomedicine SMI journal of, 2007 undefined. Nanoparticles in modern medicine: State of the art and future challenges. Taylor &FrancisSKMurthyInternational Journal of Nanomedicine, 2007•Taylor & Francis.GOOGLE SCHOLAR
  53. 53.Nguyen, H. X.; Banga, A. K.. Advanced transdermal drug delivery system: A comprehensive review of microneedle technologies, novel designs, diverse applications, and critical challenges. International Journal of Pharmaceutics. 2025;670:125118. https://doi.org/10.1016/j.ijpharm.2024.125118CrossrefGOOGLE SCHOLAR
  54. 54.Nguyen, T. T. N.; Vo, T. T.; Nguyen, B. N. H.; Nguyen, TT Vo; Nguyen, BNH; Nguyen, DT et al. Silver and gold nanoparticles biosynthesized by aqueous extract of burdock root, Arctium lappa as antimicrobial agent and catalyst for degradation of pollutants. SpringerTTN. 2018;25(34):34247–34261. https://doi.org/10.1007/S11356-018-3322-2CrossrefGOOGLE SCHOLAR
  55. 55.Nyabola, A. O.; Kareru, P. G.; Madivoli, E. S.; Wanakai, S. I.; Maina, E. G.. Formation of silver nanoparticles via AspiliaplurisetaExtracts their antimicrobial and catalytic activity. Journal of Inorganic and Organometallic Polymers and Materials. 2020;30(9):3493–3501. https://doi.org/10.1007/S10904-020-01497-7/METRICSCrossrefGOOGLE SCHOLAR
  56. 56.Pagona, G.; Tagmatarchis, N.. Carbon nanotubes: Materials for medicinal chemistry and biotechnological applications. Current Medicinal Chemistry. 2006;13(15):1789–1798. https://doi.org/10.2174/092986706777452524CrossrefGOOGLE SCHOLAR
  57. 57.Pallela, P. N. V. K.; Ummey, S.; Ruddaraju, L. K.; Pammi, S. V. N.; Yoon, S.-G.. Ultra Small, mono dispersed green synthesized silver nanoparticles using aqueous extract of Sida cordifolia plant and investigation of antibacterial activity. Microbial Pathogenesis. 2018;124:63–69. https://doi.org/10.1016/J.MICPATH.2018.08.026CrossrefGOOGLE SCHOLAR
  58. 58.Patnala, K.; Vishwas, S.; Malla, R. R.. Nanotechnology advances in breast cancer. In A theranostic and precision medicine approach for female-specific cancers. Elsevier.. 2021;271–287. https://doi.org/10.1016/B978-0-12-822009-2.00017-0CrossrefGOOGLE SCHOLAR
  59. 59.Peter, N. Tan B.. Green synthesis of nanoparticles, applications and prospects—Google Scholar. Google Scholar.GOOGLE SCHOLAR
  60. 60.Qidwai, A.; Kumar, R.; Dikshit, A.. Green synthesis of silver nanoparticles by seed of Phoenix sylvestris L. and their role in the management of cosmetics embarrassment. Green Chemistry Letters and Reviews. 2018;11(2):176–188. https://doi.org/10.1080/17518253.2018.1445301CrossrefGOOGLE SCHOLAR
  61. 61.Raghunandan, D.; Ravishankar, B.; Sharanbasava, G.; Mahesh, D. B.; Harsoor, V.; Yalagatti, M. S. et al. Anti-cancer studies of noble metal nanoparticles synthesized using different plant extracts. Cancer Nanotechnology. 2011;2(1-6):57–65. https://doi.org/10.1007/S12645-011-0014-8CrossrefGOOGLE SCHOLAR
  62. 62.Ramadan, M. A.; Shawkey, A. E.; Rabeh, M. A.; Abdellatif, A. O.. Promising antimicrobial activities of oil and silver nanoparticles obtained from Melaleuca alternifolia leaves against selected skin-infecting pathogens. Journal of Herbal Medicine. 2020;20:Article 100289. https://doi.org/10.1016/J.HERMED.2019.100289CrossrefGOOGLE SCHOLAR
  63. 63.Rautela, A.; Rani, J.; Debnath (Das), M.. Green synthesis of silver nanoparticles from Tectona grandis seeds extract: characterization and mechanism of antimicrobial action on different microorganisms. Journal of Analytical Science and Technology. 2019;10(1):1–10. https://doi.org/10.1186/S40543-018-0163-Z/FIGURES/14CrossrefGOOGLE SCHOLAR
  64. 64.Raza, M. A.; Kanwal, Z.; Rauf, A.; Sabri, A. N.; Riaz, S.; Naseem, S.. Size- and shape-dependent antibacterial studies of silver nanoparticles synthesized by wet chemical routes. Nanomaterials. 2016;6(4):74. https://doi.org/10.3390/NANO6040074CrossrefGOOGLE SCHOLAR
  65. 65.Salari, N.; Faraji, F.; Torghabeh, F. M.; Faraji, F.; Mansouri, K.; Abam, F. et al. Polymer-based drug delivery systems for anticancer drugs: A systematic review. Cancer Treatment and Research Communications. 2022;32:100605. https://doi.org/10.1016/J.CTARC.2022.100605CrossrefGOOGLE SCHOLAR
  66. 66.Samad, M. A.; Ahmad, I.; Zughaibi, T. A.; Suhail, M.; Zaidi, S. K.; Al-Abbasi, F. A. et al. Nanotechnology-based drug delivery for breast cancer treatment: Current applications and future directions. European Journal of Medicinal Chemistry Reports. 2025;14:Article 100268. https://doi.org/10.1016/J.EJMCR.2025.100268CrossrefGOOGLE SCHOLAR
  67. 67.Seleiman, M. F.; Ahmad, A.; Battaglia, M. L.; Bilal, H. M.; Alhammad, B. A.; Khan, N.. Zinc oxide nanoparticles: A unique saline stress mitigator with the potential to increase future crop production. South African Journal of Botany. 2023;159:208–218. https://doi.org/10.1016/J.SAJB.2023.06.009CrossrefGOOGLE SCHOLAR
  68. 68.Skiba, M. I.; Vorobyova, V. I.. Synthesis of silver nanoparticles using orange peel extract prepared by Plasmochemical extraction method and degradation of methylene blue under solar irradiation. Advances in Materials Science and Engineering. 2019;2019(1):1–8. https://doi.org/10.1155/2019/8306015CrossrefGOOGLE SCHOLAR
  69. 69.Sondi, I.; Salopek-Sondi, B.. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. Journal of Colloid and Interface Science. 2004;275(1):177–182. https://doi.org/10.1016/J.JCIS.2004.02.012CrossrefGOOGLE SCHOLAR
  70. 70.Subscribe to cancer treatment and research communications—2468-2942. Elsevier.GOOGLE SCHOLAR
  71. 71.Suman, T. Y.; Radhika Rajasree, S. R.; Kanchana, A.; Elizabeth, S. B.. Biosynthesis, characterization and cytotoxic effect of plant mediated silver nanoparticles using Morinda citrifolia root extract. Colloids and Surfaces. B, Biointerfaces. 2013;106:74–78. https://doi.org/10.1016/J.COLSURFB.2013.01.037CrossrefGOOGLE SCHOLAR
  72. 72.Sun, R. W.-Y.; Chen, R.; Chung, N. P.-Y.; Ho, C.-M.; Lin, C.-L. S.; Che, C.-M.. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chemical Communications (Cambridge, England). 2005;40:5059–5061. https://doi.org/10.1039/B510984ACrossrefGOOGLE SCHOLAR
  73. 73.Sun, Y.; Mayers, B.; Herricks, T.; Xia, Y.. Polyol synthesis of uniform silver nanowires: A plausible growth mechanism and the supporting evidence. Nano Letters. 2003;3(7):955–960. https://doi.org/10.1021/nl034312mCrossrefGOOGLE SCHOLAR
  74. 74.Tajaldini, M.; Samadi, F.; Khosravi, A.; Ghasemnejad, A.; Asadi, J.. Protective and anticancer effects of orange peel extract and naringin in doxorubicin treated esophageal cancer stem cell xenograft tumor mouse model. Biomedicine and Pharmacotherapy. 2020;121:Article 109594. https://doi.org/10.1016/J.BIOPHA.2019.109594CrossrefGOOGLE SCHOLAR
  75. 75.Tan, N. P. B.; Lee, C. H.; Li, P.. Green synthesis of smart metal/polymer nanocomposite particles and their tuneable catalytic activities. Polymers. 2016;8(4):105. https://doi.org/10.3390/polym8040105CrossrefGOOGLE SCHOLAR
  76. 76.Tian, Y.; Liu, X.; Chen, F.; Zheng, Y.. A facile approach to achieve subambient radiative cooling through aluminum foils and polyethylene bubble wrap. Solar Energy Materials and Solar Cells. 2021;230:Article 111286. https://doi.org/10.1016/j.solmat.2021.111286CrossrefGOOGLE SCHOLAR
  77. 77.Triantafyllakou, I.; Clemente, N.; Khetavat, R. K.; Dianzani, U.; Tselios, T.. Development of PLGA nanoparticles with a glycosylated myelin oligodendrocyte glycoprotein epitope (MOG35-55) against experimental autoimmune encephalomyelitis (EAE). Molecular Pharmaceutics. 2022;19(11):3795–3805. https://doi.org/10.1021/ACS.MOLPHARMACEUT.2C00277CrossrefGOOGLE SCHOLAR
  78. 78.Varghese, R.; Almalki, M. A.; Ilavenil, S.; Rebecca, J.; Choi, K. C.. Silver nanopaticles synthesized using the seed extract of Trigonella foenum-graecum L. and their antimicrobial mechanism and anticancer properties. Saudi Journal of Biological Sciences. 2019;26(1):148–154. https://doi.org/10.1016/J.SJBS.2017.07.001CrossrefGOOGLE SCHOLAR
  79. 79.Wang, L.; Mei, Z.; Jin, G.; Liu, H.; Lv, S.; Fu, R. et al. In situ sustained release hydrogel system delivering GLUT1 inhibitor and chemo-drug for cancer post-surgical treatment. Bioactive Materials. 2024;36:541–550. https://doi.org/10.1016/J.BIOACTMAT.2024.06.034CrossrefGOOGLE SCHOLAR
  80. 80.Yang, J.; Wang, X.; Wang, B.; Park, K.; Wooley, K.; Zhang, S.. Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers. Advanced Drug Delivery Reviews. 2022;190:Article 114525. https://doi.org/10.1016/J.ADDR.2022.114525CrossrefGOOGLE SCHOLAR
  81. 81.Yang, N.; Li, F.; Jian, T.; Liu, C.; Sun, H.; Wang, L. et al. Biogenic synthesis of silver nanoparticles using ginger (Zingiber officinale) extract and their antibacterial properties against aquatic pathogens. Acta Oceanologica Sinica. 2017;36(12):95–100. https://doi.org/10.1007/s13131-017-1099-7CrossrefGOOGLE SCHOLAR
  82. 82.Yazdi, M. H.; Sepehrizadeh, Z.; Mahdavi, M.; Shahverdi, A. R.; Faramarzi, M. A.. Metal, metalloid, and oxide nanoparticles for therapeutic and diagnostic oncology. Nano Biomedicine and Engineering. 2016;8(4):246–267. https://doi.org/10.5101/NBE.V8I4.P246-267CrossrefGOOGLE SCHOLAR
  83. 83.Yuan, T.; Fu, X.; Hu, R.; Zheng, X.; Jiang, D.; Jing, L. et al. Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance. Trends in Biotechnology. 2024;42(11):1523–1550. https://doi.org/10.1016/J.TIBTECH.2024.06.007CrossrefGOOGLE SCHOLAR
  84. 84.Zahra, Z.; Habib, Z.; Chung, S.; Badshah, M. A.. Exposure route of TiO2 NPs from industrial applications to wastewater treatment and their impacts on the agro-environment. Nanomaterials. 2020;10(8):1469. https://doi.org/10.3390/NANO10081469CrossrefGOOGLE SCHOLAR
  85. 85.Zandpour, F.; Allafchian, A. R.; Vahabi, M. R.; Jalali, S. A. H.. Green synthesis of silver nanoparticles with the Arial part of Dorema ammoniacum D. extract by antimicrobial analysis. IET Nanobiotechnology. 2018;12(4):491–495. https://doi.org/10.1049/IET-NBT.2017.0216CrossrefGOOGLE SCHOLAR
  86. 86.Zhang, X.; He, Y.; Wang, Z.; Zhang, Y.; Guo, W.; Li, S. et al. A new intracellularly regulated release pattern controlled by coordinated carrier cracking and drug release. Chemical Engineering Journal. 2024;497:Article 154514. https://doi.org/10.1016/J.CEJ.2024.154514CrossrefGOOGLE SCHOLAR
  87. 87.Zhou, N.; Gao, Y.-F.; Huo, Y.; Zhang, K.; Zhu, J.; Chen, M.-Y. et al. Biodegradable micro-nanofiber medical tape with antibacterial and unidirectional moisture permeability. Chemical Engineering Journal. 2023;474:Article 145793. https://doi.org/10.1016/J.CEJ.2023.145793CrossrefGOOGLE SCHOLAR
  88. 88.Zou, Z.; Fernández, Á. F. et al. Vega-Rubín-De-Celis S Increased autophagy blocks HER2-mediated breast tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. 2018;115(16):4176–4181. https://doi.org/10.1073/PNAS.1717800115/SUPPL_FILE/PNAS.1717800115.SD03.XLSXCrossrefGOOGLE SCHOLAR

Cite this article

SELECT FORMAT

Bonthagarala, B., Arige, S., AnupamaSri, G. N. S., Hadassa, M. Q., Jahnavi, C., Jhaneesha, C., Lakshmi, K. S. V., Sri, K. K., & Vadapalli, R. R. (2026). Emerging Trends in Silver Nanoparticle Therapies for Breast Cancer: A Comprehensive Review. International Journal of Pharmaceutical Investigation, 17(1), 21–29. https://doi.org/10.5530/ijpi.20270233